Skip to Content

Join the 'Buprenorphine / Naloxone' group to help and get support from people like you.

Buprenorphine / Naloxone News (Page 5)

FDA Medwatch Alert: Opioid Pain Medicines: Drug Safety Communication - New Safety Warnings Added to Prescription Opioid Medications

ISSUE: FDA is warning about several safety issues with the entire class of opioid pain medicines. See the FDA Drug Safety Communication for a complete listing. These safety risks are potentially h...

FDA Approves Zubsolv for Induction of Buprenorphine Maintenance Therapy in Patients Suffering from Opioid Dependence

Uppsala, Sweden – August 11, 2015 - Orexo AB (publ) announced today that the U.S. Food and Drug Administration (FDA) has approved Zubsolv (buprenorphine/naloxone CIII sublingual tablet) for induction ...

FDA Approves Two Higher Dosage Strengths of Zubsolv

Uppsala, Sweden – December 12, 2014 – Orexo AB announces today that it has received approval from the U.S. Food and Drug Administration (FDA) of two higher dosage strengths of Zubsolv (bu...

FDA Approves Zubsolv for the Maintenance Treatment of Opioid Dependence

Uppsala, Sweden – July 4, 2013 – Orexo today announced that it has received approval from the U.S. Food and Drug Administration (FDA) for Zubsolv (buprenorphine/naloxone) sublingual tablet CIII. Zub...

Ask a Question

Want to post your own question to this support group? You'll need to first create an account with (or sign in to your existing account).

Further Information

Related Condition Support Groups

Opiate Dependence

Related Drug Support Groups


Buprenorphine / Naloxone Patient Information at